Skip to main content

MoneyWorks4Me

Glenmark Pharmaceuticals informs about press release

28 Jun 2019 Evaluate

Glenmark Pharmaceuticals has informed that it has enclosed press release titled 'Glenmark Pharmaceuticals receives ANDA approval for Ezetimibe and Simvastatin Tablets, 10 mg/10 mg, 10 mg/20 mg, 10 mg/40 mg, and 10 mg/80 mg'.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1797.45
Dr. Reddys Labs. 1351.40
Cipla 1371.40
Lupin 1992.60
Zydus Lifesciences 1204.45
View more..